Satellos Bioscience Inc ICOTF

Primary Symbol: T.MSCL Alternate Symbol(s): MSCLF

Healthcare Biotechnology

Satellos Bioscience Inc. is a Canada-based biotechnology company. The Company is engaged in developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders. The Company is focused on the research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX, to identify degenerative muscle diseases where deficits in this process affect muscle regeneration and are amenable to therapeutic intervention. With this platform, the Company is building a pipeline of therapeutics to correct muscle stem cell polarity and promote the body’s innate muscle repair and regeneration process. The Company’s lead program is an oral, small molecule drug candidate in development as a potential disease-modifying treatment for Duchenne muscular dystrophy. It has wholly owned subsidiaries in Australia (Satellos Bioscience Australia Pty Ltd), in Canada (Amphotericin B Technologies, Inc.) and in Delaware, USA (Satellos Bioscience US, Inc.).

TSX:MSCL - Post by User

Satellos Bioscience Inc

<< Previous

Bullboard Posts

Next >>

Post by jomagon Feb 25, 2021 9:58am

91 Views

Post# 32656893

Leede fake wall... Anonynous buying !!!!!

V:ICO Depth by Order @09:57:12

Bid			Ask
Broker	Size	Price	Price	Size	Broker
1 Anonymous	10,000	0.13	0.135	405,000	68 Leede
2 RBC	4,500	0.13	0.135	15,000	1 Anonymous
79 CIBC	30,000	0.13	0.135	250,000	68 Leede
1 Anonymous	5,000	0.13	0.14	250,000	68 Leede
1 Anonymous	20,000	0.13	0.14	400,000	68 Leede
80 National Bank	20,000	0.13	0.14	100,000	85 Scotia
88 Credential	500,000	0.13	0.14	89,500	7 TD Sec
33 Canaccord	30,000	0.125	0.145	33,000	2 RBC
85 Scotia	20,000	0.125	0.145	12,000	7 TD Sec
7 TD Sec	36,000	0.125	0.145	10,000	1 Anonymous